First, we examined the expression levels of GLP-1R using immunohistochemistry staining in the livers of patients that were diagnosed with NAFLD by liver biopsy and in normal controls. The gene discussed is GLP1R; the disease is metabolic dysfunction-associated steatotic liver disease.